167 related articles for article (PubMed ID: 18325101)
21. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Taniguchi T; Tischkowitz M; Ameziane N; Hodgson SV; Mathew CG; Joenje H; Mok SC; D'Andrea AD
Nat Med; 2003 May; 9(5):568-74. PubMed ID: 12692539
[TBL] [Abstract][Full Text] [Related]
22. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents.
Jun DW; Hwang M; Kim HJ; Hwang SK; Kim S; Lee CH
PLoS One; 2013; 8(10):e75905. PubMed ID: 24124520
[TBL] [Abstract][Full Text] [Related]
23. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
24. Alcohol metabolism in human cells causes DNA damage and activates the Fanconi anemia-breast cancer susceptibility (FA-BRCA) DNA damage response network.
Abraham J; Balbo S; Crabb D; Brooks PJ
Alcohol Clin Exp Res; 2011 Dec; 35(12):2113-20. PubMed ID: 21919919
[TBL] [Abstract][Full Text] [Related]
25. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
Wang H; Bierie B; Li AG; Pathania S; Toomire K; Dimitrov SD; Liu B; Gelman R; Giobbie-Hurder A; Feunteun J; Polyak K; Livingston DM
Mol Cell; 2016 Jul; 63(2):277-292. PubMed ID: 27373334
[TBL] [Abstract][Full Text] [Related]
26. MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy.
Bi J; Areecheewakul S; Li Y; Yang S; Zhang Y; Ebeid K; Li L; Thiel KW; Zhang J; Dai D; Salem AK; Leslie KK; Meng X
Gynecol Oncol; 2019 Nov; 155(2):349-358. PubMed ID: 31477281
[TBL] [Abstract][Full Text] [Related]
27. Lung cancer cell line screen links fanconi anemia/BRCA pathway defects to increased relative biological effectiveness of proton radiation.
Liu Q; Ghosh P; Magpayo N; Testa M; Tang S; Gheorghiu L; Biggs P; Paganetti H; Efstathiou JA; Lu HM; Held KD; Willers H
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1081-9. PubMed ID: 25832698
[TBL] [Abstract][Full Text] [Related]
28. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract][Full Text] [Related]
29. ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma.
Bretz AC; Gittler MP; Charles JP; Gremke N; Eckhardt I; Mernberger M; Mandic R; Thomale J; Nist A; Wanzel M; Stiewe T
Nucleic Acids Res; 2016 Apr; 44(7):3204-18. PubMed ID: 26819410
[TBL] [Abstract][Full Text] [Related]
30. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.
Landais I; Sobeck A; Stone S; LaChapelle A; Hoatlin ME
Int J Cancer; 2009 Feb; 124(4):783-92. PubMed ID: 19048618
[TBL] [Abstract][Full Text] [Related]
31. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
[TBL] [Abstract][Full Text] [Related]
32. Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblot.
Van Der Heijden MS; Brody JR; Kern SE
Cancer Biol Ther; 2004 Jun; 3(6):534-7. PubMed ID: 15107617
[TBL] [Abstract][Full Text] [Related]
33. Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells.
Oda Y; Hidaka M; Suzuki A
Biol Pharm Bull; 2017 Nov; 40(11):2005-2009. PubMed ID: 28855448
[TBL] [Abstract][Full Text] [Related]
34. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
[TBL] [Abstract][Full Text] [Related]
35. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
Guervilly JH; Macé-Aimé G; Rosselli F
Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells.
Zhang J; Wang X; Lin CJ; Couch FJ; Fei P
Cancer Biol Ther; 2006 Dec; 5(12):1632-6. PubMed ID: 17106252
[TBL] [Abstract][Full Text] [Related]
37. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathogenesis of fanconi anemia.
Taniguchi T; Dandrea AD
Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
[TBL] [Abstract][Full Text] [Related]
39. [Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway].
Xiao H; Zhang KJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):804-8. PubMed ID: 18718065
[TBL] [Abstract][Full Text] [Related]
40. New roads to FA/BRCA pathway: H2AX.
Lyakhovich A; Surrallés J
Cell Cycle; 2007 May; 6(9):1019-23. PubMed ID: 17471025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
